RASTRUM™ Allegro: A Game-Changer for 3D Cell Model Research – Is Your Team Ready?

As a recruiter working heavily within the service engineering field, I have seen how cutting-edge technologies reshape research and development. One of the most significant advancements in recent years is the shift towards 3D cell models in drug discovery and disease research. These models provide a far more physiologically relevant alternative to traditional 2D cultures, improving the accuracy of preclinical studies and accelerating the development of new therapies.

With the launch of RASTRUM™ Allegro by Inventia Life Science, the barriers to high-throughput, reproducible 3D cell model generation have been removed. But while technology is advancing, does your organisation have the right expertise in place to maximise its potential?

Why Are 3D Cell Models the Future?

3D cell cultures offer significant advantages over traditional 2D models, particularly in oncology, regenerative medicine, and drug screening.

– More Biologically Relevant – 3D models replicate human tissue architecture more accurately than 2D cultures.

– Better Drug Testing – They enable a deeper understanding of cell-to-cell interactions, tumour microenvironments, and drug responses.

– Higher Accuracy and Reliability – More robust and reproducible data reduces failures in the drug development pipeline.

Despite these advantages, traditional methods for creating 3D models have been slow, inconsistent, and resource-intensive, limiting their widespread adoption. RASTRUM Allegro is addressing these challenges.

How is RASTRUM™ Allegro Changing the Industry?

RASTRUM Allegro is an automated 3D cell culture platform that enables rapid and scalable production of biologically relevant models. By combining drop-on-demand bioprinting technology with precision robotics, it allows scientists to generate complex multicellular environments that mimic real tissue structures with high throughput.

What This Means for Hiring in Biotech and Pharma

Technologies like RASTRUM Allegro are redefining the skill sets required in research teams. As automation and high-throughput screening become industry standards in 3D cell culture and translational research, organisations will need professionals who can:

– Optimise automated workflows for bioprinting and high-content screening.

– Interpret complex 3D cell culture data and integrate findings into drug development pipelines.

– Develop tailored bioengineered microenvironments for disease modelling.

– Bridge the gap between automation, AI-driven analytics, and laboratory research.

I am seeing a growing demand for specialists in 3D cell culture, tissue engineering, bioinformatics, and high-throughput screening. Companies that invest in the right expertise now will be best positioned to drive innovation in drug discovery and personalised medicine.

Is Your Team Ready?

RASTRUM Allegro is making scalable, reproducible 3D cell culture a reality. However, technology alone is not enough—success depends on the right team.

If your organisation is investing in 3D models for drug discovery, now is the time to evaluate your hiring strategy. Do you have the scientists, bioengineers, and data specialists needed to fully leverage these advancements?

If not, let’s start a conversation. Get in touch to discuss how to build a world-class 3D cell modelling team.